Your browser doesn't support javascript.
loading
Evaluation of Cost-Effectiveness of Adjuvant Osimertinib in Patients with Resected EGFR Mutation-Positive Non-small Cell Lung Cancer.
Verhoek, Andre; Cheema, Parneet; Melosky, Barbara; Samson, Benoit; Shepherd, Frances A; de Marinis, Filippo; John, Thomas; Wu, Yi-Long; Heeg, Bart; Van Dalfsen, Nadia; Bracke, Benjamin; Miranda, Miguel; Shaw, Simon; Moldaver, Daniel.
Afiliación
  • Verhoek A; Cytel, Weena 316-318, 3012 NJ, Rotterdam, The Netherlands. andre.verhoek@cytel.com.
  • Cheema P; William Osler Health System, University of Toronto, Toronto, ON, Canada.
  • Melosky B; Department of Medical Oncology, BC Cancer, Vancouver, BC, Canada.
  • Samson B; Charles LeMoyne Hospital Cancer Center, Greenfield Park, QC, Canada.
  • Shepherd FA; Department of Medical Oncology and Hematology, University Health Network, Princess Margaret Cancer Centre and the University of Toronto, Toronto, ON, Canada.
  • de Marinis F; Division of Thoracic Oncology, European Institute of Oncology, IRCCS, Milan, Italy.
  • John T; Department of Medical Oncology, Austin Health, Melbourne, VIC, Australia.
  • Wu YL; Department of Oncology, Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Guangzhou, People's Republic of China.
  • Heeg B; Cytel, Weena 316-318, 3012 NJ, Rotterdam, The Netherlands.
  • Van Dalfsen N; Cytel, Weena 316-318, 3012 NJ, Rotterdam, The Netherlands.
  • Bracke B; Global Health Economics and Payer Evidence, AstraZeneca, Cambridge, UK.
  • Miranda M; Global Medical Development, AstraZeneca, Cambridge, UK.
  • Shaw S; Global Medical Affairs, AstraZeneca, Cambridge, UK.
  • Moldaver D; Health Economics and Payer Evidence, AstraZeneca, Mississauga, ON, Canada.
Pharmacoecon Open ; 7(3): 455-467, 2023 May.
Article en En | MEDLINE | ID: mdl-36811822
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Health_economic_evaluation / Prognostic_studies Idioma: En Revista: Pharmacoecon Open Año: 2023 Tipo del documento: Article País de afiliación: Países Bajos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Health_economic_evaluation / Prognostic_studies Idioma: En Revista: Pharmacoecon Open Año: 2023 Tipo del documento: Article País de afiliación: Países Bajos